A new report from the Patented Medicine Prices Review Board
(PMPRB) compares generic drug prices in Canada
with those of other industrialized nations. The report was released
in August 2013 and highlights changes in generic pricing between
2008 and the first quarter of (Q1-) 2011.
Although generic drug prices in Canada have been markedly
reduced, mean international prices are still 35% lower than
Canada's. Yet, the gap between brand-name and generic prices
has increased in Canada. In Q1-2009 and Q1-2010 generic drugs were
priced at 68% – 69% of the brand-name price; generics were
priced at 64% in Q1-2011.
The analysis also conducted a bilateral comparison of Ontario
formulary prices with those of 11 industrialized countries.
Analysis focused on the top 50 selling generic drugs. These
drugs accounted for nearly half of generic sales in the
country. The results suggest that in Q1-2011, prices in
Ontario for the top 50 generic drugs were higher than the
corresponding foreign prices. Only Australia and Switzerland
had on average higher prices than Ontario.
The PMPRB issued a similar report in 2011, examining market
structure trends of seven industrialized countries. Reported price
ratios were well below parity and ranged from 42% (Sweden) to 73%
(France) of Canadian prices. Despite recent attempts at the
provincial level to address this disparity, the PMPRB's most
recent report suggests that Ontarians — and Canadians —
are still paying comparatively higher prices for generics.
Norton Rose Fulbright is a global legal practice. We provide
the world's pre-eminent corporations and financial institutions
with a full business law service. We have more than 3800 lawyers
based in over 50 cities across Europe, the United States, Canada,
Latin America, Asia, Australia, Africa, the Middle East and Central
Recognized for our industry focus, we are strong across all
the key industry sectors: financial institutions; energy;
infrastructure, mining and commodities; transport; technology and
innovation; and life sciences and healthcare.
Wherever we are, we operate in accordance with our global
business principles of quality, unity and integrity. We aim to
provide the highest possible standard of legal service in each of
our offices and to maintain that level of quality at every point of
Norton Rose Fulbright LLP, Norton Rose Fulbright Australia,
Norton Rose Fulbright Canada LLP, Norton Rose Fulbright South
Africa (incorporated as Deneys Reitz Inc) and Fulbright &
Jaworski LLP, each of which is a separate legal entity, are members
('the Norton Rose Fulbright members') of Norton Rose
Fulbright Verein, a Swiss Verein. Norton Rose Fulbright Verein
helps coordinate the activities of the Norton Rose Fulbright
members but does not itself provide legal services to
The content of this article is intended to provide a
general guide to the subject matter. Specialist advice should be
sought about your specific circumstances.
To print this article, all you need is to be registered on Mondaq.com.
Click to Login as an existing user or Register so you can print this article.
Effective September 1, 2016, the Disposition of Surplus Real Property Regulation to the Ontario Education Act was amended with the intention to reduce barriers to the formation of health and community hubs in Ontario.
This appeal relates to two generic drug submissions for two different products: exemestane and infliximab. Both submissions cross-referenced the submission of another generic company that had received a Notice of Compliance.
Two recent decisions from the Supreme Court of Canada directly affect Quebec's farm businesses by confirming La Financière Agricole du Québec's discretion in the administration of the farm income stabilization program...
On October 6, 2016, the Ontario Legislature reintroduced the Patients First Act, 2016 as Bill 41. Bill 41 is very similar to its predecessor, Bill 210, which was introduced in June 2016, but makes some important changes to the previous bill.
Register for Access and our Free Biweekly Alert for
This service is completely free. Access 250,000 archived articles from 100+ countries and get a personalised email twice a week covering developments (and yes, our lawyers like to think you’ve read our Disclaimer).